Recalled Phillips Sleep Apnea Devices Could Approach 15 Million Units Or More

In 2015, Phillips failed to investigate reports one of their units were repairing foam degradation of Trilogy Ventilators

Wednesday, November 24, 2021 - The results of a recent FDA investigation into the Phillips CPAP sleep apnea devices recall has concluded that the number of machines under recall is much higher than we were told at first by the manufacturer. AboutLawsuits.com (AL) tells readers that FDA inspection reports that the 3 million-unit Phillips CPAP recall in the summer of 2021 fell far short of the 15 million units that were defective and were injuring users. People who have developed cancer or another serious respiratory illness as a result of using a Philips CPAP breathing machine or mechanical ventilator may be eligible for lump-sum monetary compensation by filing a Philips CPAP cancer lawsuit. The report also suggests that Phillips was non-responsive when the first reports of the machine's problems were made to them years ago. "While initial media reports suggested that Philips Respironics was recalling about 3 million DreamStation, CPAP, BiPAP, and mechanical ventilators in June 2021, the FDA inspection report (PDF) issued late last week indicates that over 15 million devices have been recalled, and that may not include all CPAP machines that pose a health risk for consumers," according to AL.

Phillips defends their actions by citing that the Phillips CPAP recalls are ongoing and have no formal start or stop date. The FDA tells consumers that the Trilogy ventilator devices should have also been included in the company's Class I recall years ago when complaints were made but were not. The report goes on to say that Phillips should have been aware of the Trilogy device's noise abatement foam deterioration problem as early as November 11, 2015, when other units within the company were making such repairs. The FDA has accused Phillips of failing to take action after the company became aware that another unit of the company had performed service on the noise abatement foam used on the Trilogy model and took no further actions. The FDA or around 11/25/15, your firm was aware and knowledgable of a preventative maintenance servicing procedure implemented by another Phillips entity on Trilogy ventilator products, and no further investigation, health hazard evaluation, risk analysis, or design review was performed, or documented by your firm. The preventative maintenance was implemented by Phillips LTD, (the other entity) only, and in response to foam degradation issues and complaints in the field related to Trilogy ventilator products." The FDA report lays bare that Phillips continued to market their sleep apnea machines and even highlighted their quiet operation because of the PE-PUR noise abatement foam that the company either knew or had an obligation to know was degrading and releasing toxic, carcinogenic particles, chemicals and gassed directly into the machine's airway to be inhaled by the user.

Failing to immediately investigate reports of foam degradation reflects poorly on the company and is in line with the lack of effort the company has put into recalling and replacing the 3 million Phillips CPAP units under the current recall. In October, Attorney General William Tong instructed the Food and Drug Administration (FDA) to increase its supervision efforts and pressure Royal Phillips to speed up the repair and replacement of millions of Phillips Sleep Apnea devices.

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.